We only test for the potentially diverted substances and have had “panels” that will go after the standard drugs of diversion. If there is no reasonable suspicion based on behaviors of employee(s) this is what we used. If It is truly a reasonable suspicion based on behaviors, clinical stigmata etc we do our standard reasonable suspicion which does include marijuana.
Miriam Alexander, MD MPH
Medical Director for Employee Health and Wellness
AVP Occupational Health
LifeBridge Health
2401 W.Belvedere Ave., Hoffberger 54
Baltimore, MD 21215
Phone: 410-601-0563
Mobile: 410-206-0579
Fax: 410-601-4643
From: MCOH-EH <mcoh-eh-bounces+mhalexan=lifebridgehealth.org@mylist.net>
On Behalf Of Deanna Prater via MCOH-EH
Sent: Wednesday, June 24, 2026 7:29 PM
To: MCOH-EH <mcoh-eh@mylist.net>
Cc: Deanna Prater <dprater@luhonline.com>
Subject: [MCOH-EH] for cause/reasonable suspicion drug testing
|
LBH SECURITY ALERT: This email is from an external source. Do not click on any links or open attachments unless you recognize the sender and know the content is safe. Never provide your username or password. |
We are reviewing our employee health and occupational testing policies for medication discrepancy or diversion investigations (e.g., dropped controlled substances, unresolved medication count variances). In these situations, does your organization utilize targeted drug testing panels that exclude THC/marijuana, focusing instead on relevant controlled substances associated with the discrepancy? If so, are these panels standard or ordered case-by-case? The reason I am asking, is because marijuana is legal in Oregon, and if the employee would test positive for marijuana when we're really concerned about the results for the missing substance, it could be problematic.